CTAT Conjugation for Diagnostics & Antibody Drug Conjugates (ADC’s)
The CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A Biosynth Case Study This
Read moreThe CTAT Enzymatic Antibody Drug Conjugation Technology -Benefits for Diagnostic Applications and ADC’s for Oncology. A Biosynth Case Study This
Read moreIn a significant move to expand its oncology portfolio, Taiho Pharmaceutical Co., Ltd. has entered a definitive agreement to fully
Read moreA groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read moreDarkAdapt, an advanced extension of the OptoDrum system, enables precise and reproducible studies with dark-adapted rodents. This innovative instrument provides
Read moreCutting-edge CacoReady Cell-based Plates with pre-developed Caco-2 cells for in vitro permeability assessment have been a key tool in a
Read moreBioEcho has developed a new range of rapid viral RNA/DNA extraction kits designed for a one-step extraction of viral RNA
Read moreGroundbreaking research from Harvard Medical School indicates that vision loss caused by optic nerve damage, glaucoma, and aging may not
Read morePfizer announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS® (brentuximab vedotin) in combination with
Read moreThe Ksander Lab at Boston’s Schepens Eye Research Institute has unveiled valuable insights into the role of subretinal microglia in
Read moreViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced today that
Read more